Currently, both disruption of mGluR5-mediated production of 2-AG [38, 41–43] and enhanced CB1R activation [68], which are downstream of overactivated mGluR5 [8], are suggested to underlie phenotypic traits observed in FXS [39]. The gene discussed is CNR1; the disease is fragile X syndrome.